Terazosin Tablets
These tablets are indicated to alleviate outlet obstruction and utilized to support urinary flow in men with prostate enlargement.
Strengths: 1 · 2 · 5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Hytrin
- Therapeutic class
Alpha-blocker
- Pharmacological class
Alpha-1 receptor antagonist
- Contraindications
hypersensitivity to terazosin; history of micturition syncope
- Minor side effects
dizziness; headache; nasal congestion
- Moderate side effects
peripheral oedema; fatigue; somnolence; palpitations
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Abbott
- Onset Time
1–2 hours
- Duration
24 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
other antihypertensives; phosphodiesterase-5 inhibitors
- Age restrictions
Adult use only.
- Pregnancy and breastfeeding
Pregnancy: Not applicable. Breastfeeding: Not applicable.
Precautions and warnings
risk of postural hypotension; avoid standing up quickly after dosing; do not drive if dizziness occurs
Serious side effects
syncope — requires immediate medical attention; priapism — requires immediate medical attention
Patient summary
These tablets are indicated to alleviate outlet obstruction and utilized to support urinary flow in men with prostate enlargement.
Mechanism of action
Terazosin selectively blocks alpha-1 adrenergic receptors, relaxing smooth muscle in the prostate and bladder neck, and reducing vascular resistance.
Terazosin Tablets
These tablets are indicated to alleviate outlet obstruction and utilized to support urinary flow in men with prostate enlargement.
Editorial Notes
- Active ingredient(s): Terazosin
- Listed indication(s): Benign Prostatic Hyperplasia, Hypertension
Usually available as
- 120 tablets - 1 mg1334-1-mg-15989
- 60 tablets - 2 mg1334-2-mg-15993
- 60 tablets - 5 mg1334-5-mg-15998